128 related articles for article (PubMed ID: 11374178)
1. [Detection and significance of plasminogen activator inhibitor in synovial tissue, synovial fluid and plasma from patients with rheumatoid arthritis].
Yang C; Huang F
Zhonghua Nei Ke Za Zhi; 2000 Oct; 39(10):690-3. PubMed ID: 11374178
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
Nonaka T; Kikuchi H; Ikeda T; Okamoto Y; Hamanishi C; Tanaka S
J Rheumatol; 2000 Apr; 27(4):997-1004. PubMed ID: 10782829
[TBL] [Abstract][Full Text] [Related]
3. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
[TBL] [Abstract][Full Text] [Related]
4. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
[TBL] [Abstract][Full Text] [Related]
5. Plasminogen activators and plasminogen activator inhibitors in synovial fluid. Difference between inflammatory joint disorders and osteoarthritis.
Saxne T; Lecander I; Geborek P
J Rheumatol; 1993 Jan; 20(1):91-6. PubMed ID: 8441174
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
Chu SC; Yang SF; Lue KH; Hsieh YS; Hsiao TY; Lu KH
J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
[TBL] [Abstract][Full Text] [Related]
7. Polyamine levels in synovial tissues and synovial fluids of patients with rheumatoid arthritis.
Yukioka K; Wakitani S; Yukioka M; Furumitsu Y; Shichikawa K; Ochi T; Goto H; Matsui-Yuasa I; Otani S; Nishizawa Y
J Rheumatol; 1992 May; 19(5):689-92. PubMed ID: 1613696
[TBL] [Abstract][Full Text] [Related]
8. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
Blaschke S; Schulz H; Schwarz G; Blaschke V; Müller GA; Reuss-Borst M
J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
[TBL] [Abstract][Full Text] [Related]
9. Enhanced local production of osteopontin in rheumatoid joints.
Ohshima S; Yamaguchi N; Nishioka K; Mima T; Ishii T; Umeshita-Sasai M; Kobayashi H; Shimizu M; Katada Y; Wakitani S; Murata N; Nomura S; Matsuno H; Katayama R; Kon S; Inobe M; Uede T; Kawase I; Saeki Y
J Rheumatol; 2002 Oct; 29(10):2061-7. PubMed ID: 12375312
[TBL] [Abstract][Full Text] [Related]
10. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
Steiner G; Studnicka-Benke A; Witzmann G; Höfler E; Smolen J
J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
[TBL] [Abstract][Full Text] [Related]
11. [Membrane and cytoplasmic expression of urokinase-type plasminogen activator receptor in synovial tissues of rheumatoid arthritis patients].
Zhou JG; Guo XL; Yuan GH; Wei J; Tang Z; Yang MH
Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):131-4. PubMed ID: 17445440
[TBL] [Abstract][Full Text] [Related]
12. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
[TBL] [Abstract][Full Text] [Related]
13. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
Pelletier JP; McCollum R; Cloutier JM; Martel-Pelletier J
Br J Rheumatol; 1992; 31 Suppl 1():19-26. PubMed ID: 1555050
[TBL] [Abstract][Full Text] [Related]
14. Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis.
Rovensky J; Imrich R; Radikova Z; Simorova E; Greguska O; Vigas M; Macho L
Endocr Regul; 2005 Jan; 39(1):1-6. PubMed ID: 16107132
[TBL] [Abstract][Full Text] [Related]
15. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
Yukioka K; Inaba M; Furumitsu Y; Yukioka M; Nishino T; Goto H; Nishizawa Y; Morii H
J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
[TBL] [Abstract][Full Text] [Related]
16. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
Ahrens D; Koch AE; Pope RM; Stein-Picarella M; Niedbala MJ
Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
[TBL] [Abstract][Full Text] [Related]
17. Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis.
Yazar M; Sarban S; Kocyigit A; Isikan UE
Biol Trace Elem Res; 2005 Aug; 106(2):123-32. PubMed ID: 16116244
[TBL] [Abstract][Full Text] [Related]
18. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
[TBL] [Abstract][Full Text] [Related]
19. Mobilization of fibrinolytic enzymes in synovial fluid and plasma of rheumatoid arthritis and spondyloarthropathy and their relation to radiological destruction.
Wållberg-Jonsson S; Rantapää-Dahlqvist S; Nordmark L; Rånby M
J Rheumatol; 1996 Oct; 23(10):1704-9. PubMed ID: 8895144
[TBL] [Abstract][Full Text] [Related]
20. Functional autoantibodies against serpin E2 in rheumatoid arthritis.
Maciejewska-Rodrigues H; Al-Shamisi M; Hemmatazad H; Ospelt C; Bouton MC; Jäger D; Cope AP; Charles P; Plant D; Distler JH; Gay RE; Michel BA; Knuth A; Neidhart M; Gay S; Jüngel A
Arthritis Rheum; 2010 Jan; 62(1):93-104. PubMed ID: 20039430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
